The Global Biotech Epicenter | New England Now and in 2030 - 2022 World Medical Innovation Forum

The Global Biotech Epicenter | New England Now and in 2030

The Global Biotech Epicenter | New England Now and in 2030

Tuesday, May 3, 2022

9:05 AM – 9:45 AM America Ballroom View Here

This panel will feature a discussion of global biotech clusters with a deep dive into the New England/Boston area. How does the capital availability, scale, and density of New England drive local growth in GCT? Also, the influx of large biopharmaceutical companies into the region has fueled global outcomes. What is the future impact of these investments and when will they peak? How will the biopharmaceutical landscape in New England appear in 2030?

Moderator:
Anne Finucane
  • Chairman of the Board, Bank of America Europe
Panelists:
Seth Ettenberg, PhD
  • President & CEO, BlueRock Therapeutics
Joel Marcus
  • Executive Chairman & Founder, Alexandria Real Estate Equities, Inc.
Terry McGuire
  • Founding Partner, Polaris Partners
Vicki Sato, PhD
  • Chairman of the Board, Vir Biotechnology
  • Chairman, Denali Therapeutics
Phillip Sharp, PhD
  • Institute Professor and Professor of Biology, Koch Institute for Integrative Cancer Research at MIT
  • Co-Founder, Alnylam Pharmaceuticals, Inc.